Search research articles
Contact Us
Filters
Showing results (111-120 of 121) with videos related to
Page
of 13
Sort By:
Behavioral Neuroscience
|
January 20, 2006
Cocaine treatment and prenatal environment interact to disrupt intergenerational maternal behavior in rats
Josephine M Johns, Deborah L Elliott, Vivian E Hofler, et al.
Journal of Medicinal Chemistry
|
October 28, 2015
Targeting the Src Homology 2 (SH2) Domain of Signal Transducer and Activator of Transcription 6 (STAT6) with Cell-Permeable, Phosphatase-Stable Phosphopeptide Mimics Potently Inhibits Tyr641 Phosphorylation and Transcriptional Activity
Pijus K Mandal, Pietro Morlacchi, J Morgan Knight, et al.
British Journal of Pharmacology
|
June 2, 2024
Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushrooms
Ryan J Rakoczy, Grace N Runge, Abhishek K Sen, et al.
Nature Communications
|
December 16, 2014
STAT3 restrains RANK- and TLR4-mediated signalling by suppressing expression of the E2 ubiquitin-conjugating enzyme Ubc13
Huiyuan Zhang, Hongbo Hu, Nathaniel Greeley, et al.
The Journal of Biological Chemistry
|
May 10, 2018
Small molecule targeting of the STAT5/6 Src homology 2 (SH2) domains to inhibit allergic airway disease
J Morgan Knight, Pijus Mandal, Pietro Morlacchi, et al.
The Journal of Experimental Medicine
|
January 30, 2013
Notch activation inhibits AML growth and survival: a potential therapeutic approach
Sankaranarayanan Kannan, Robert M Sutphin, Mandy G Hall, et al.
Plos One
|
September 10, 2013
The antihelmintic drug pyrvinium pamoate targets aggressive breast cancer
Wei Xu, Lara Lacerda, Bisrat G Debeb, et al.
Oncogene
|
April 4, 2017
Interferon γ is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells
H S Madapura, N Nagy, D Ujvari, et al.
Medchemcomm
|
August 16, 2018
The discovery of a potent Na<sub>v</sub>1.3 inhibitor with good oral pharmacokinetics
D C Pryde, N A Swain, P A Stupple, et al.
Plos One
|
November 26, 2015
Long-Acting Beta Agonists Enhance Allergic Airway Disease
John M Knight, Garbo Mak, Joanne Shaw, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 121) with videos related to
Sort By:
Page
of 13
Behavioral Neuroscience
|
January 20, 2006
Cocaine treatment and prenatal environment interact to disrupt intergenerational maternal behavior in rats
Josephine M Johns, Deborah L Elliott, Vivian E Hofler, et al.
Journal of Medicinal Chemistry
|
October 28, 2015
Targeting the Src Homology 2 (SH2) Domain of Signal Transducer and Activator of Transcription 6 (STAT6) with Cell-Permeable, Phosphatase-Stable Phosphopeptide Mimics Potently Inhibits Tyr641 Phosphorylation and Transcriptional Activity
Pijus K Mandal, Pietro Morlacchi, J Morgan Knight, et al.
British Journal of Pharmacology
|
June 2, 2024
Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushrooms
Ryan J Rakoczy, Grace N Runge, Abhishek K Sen, et al.
Nature Communications
|
December 16, 2014
STAT3 restrains RANK- and TLR4-mediated signalling by suppressing expression of the E2 ubiquitin-conjugating enzyme Ubc13
Huiyuan Zhang, Hongbo Hu, Nathaniel Greeley, et al.
The Journal of Biological Chemistry
|
May 10, 2018
Small molecule targeting of the STAT5/6 Src homology 2 (SH2) domains to inhibit allergic airway disease
J Morgan Knight, Pijus Mandal, Pietro Morlacchi, et al.
The Journal of Experimental Medicine
|
January 30, 2013
Notch activation inhibits AML growth and survival: a potential therapeutic approach
Sankaranarayanan Kannan, Robert M Sutphin, Mandy G Hall, et al.
Plos One
|
September 10, 2013
The antihelmintic drug pyrvinium pamoate targets aggressive breast cancer
Wei Xu, Lara Lacerda, Bisrat G Debeb, et al.
Oncogene
|
April 4, 2017
Interferon γ is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells
H S Madapura, N Nagy, D Ujvari, et al.
Medchemcomm
|
August 16, 2018
The discovery of a potent Na<sub>v</sub>1.3 inhibitor with good oral pharmacokinetics
D C Pryde, N A Swain, P A Stupple, et al.
Plos One
|
November 26, 2015
Long-Acting Beta Agonists Enhance Allergic Airway Disease
John M Knight, Garbo Mak, Joanne Shaw, et al.
Page
of 13